Jason Duncan - 22 Jul 2021 Form 4 Insider Report for ALBIREO PHARMA, INC.

Role
Chief Legal Officer and GC
Signature
/s/ Jason Duncan
Issuer symbol
N/A
Transactions as of
22 Jul 2021
Net transactions value
-$10,081
Form type
4
Filing time
26 Jul 2021, 16:05:18 UTC
Previous filing
28 Jun 2021
Next filing
25 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Sale $3,072 -90 -1.1% $34.13 7,890 22 Jul 2021 Direct F1, F2
transaction ALBO Common Stock Sale $7,009 -223 -2.8% $31.43 7,667 23 Jul 2021 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 Represents 515 shares of common stock and 7,375 restricted stock units.
F3 Shares sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
F4 Represents 292 shares of common stock and 7,375 restricted stock units.